Post job

Competitor Summary. See how Quinnova Pharmaceuticals Including Sarms, Peptides and More compares to its main competitors:

  • Shionogi has the most employees (6,082).
Work at Quinnova Pharmaceuticals Including Sarms, Peptides and More?
Share your experience

Quinnova Pharmaceuticals Including Sarms, Peptides and More vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
2003
3.4
Newtown, PA1$5.3M75
1989
4.2
Raleigh, NC2$1.1B1,000
1946
4.3
San Antonio, TX2$140.0M750
2004
4.3
West Chester, PA1$8.6M71
2000
3.9
Scottsdale, AZ1$17.5M50
1878
4.4
Florham Park, NJ2$50.0M6,082
2001
4.2
Irvine, CA2$3.1M31
1981
3.5
Amityville, NY1$11.5M150
1996
3.8
Morristown, NJ1$146.1M171
2006
4.4
Emeryville, CA1$81.7M90
1996
4.5
San Diego, CA1$218.0M290
2006
3.6
Scottsdale, AZ1$670,00042
2005
4.6
Deerfield, IL7$25.0M30
2002
3.1
Ridgeland, MS1$4.3M25
2011
3.9
Alpharetta, GA1$11.0M206
2006
4.6
Atlanta, GA1$175.0M157
1985
4.3
Fairfield, NJ1$145.0M300
-
3.9
Bridgewater, NJ1$29.0M375
FarmVet
2000
3.5
Franklin, TN1$1.6M15
2008
3.4
Cranford, NJ1$85.0M125
1991
4.4
Wilmington, MA1$45.3M50

Rate how well Quinnova Pharmaceuticals Including Sarms, Peptides and More differentiates itself from its competitors.

Zippia waving zebra

Quinnova Pharmaceuticals Including Sarms, Peptides and More salaries vs competitors

Compare Quinnova Pharmaceuticals Including Sarms, Peptides and More salaries vs competitors

CompanyAverage salaryHourly salarySalary score
Quinnova Pharmaceuticals Including Sarms, Peptides and More
$67,181$32.30-

Compare Quinnova Pharmaceuticals Including Sarms, Peptides and More job title salaries vs competitors

CompanyHighest salaryHourly salary
Quinnova Pharmaceuticals Including Sarms, Peptides and More
$72,503$34.86
Salix Pharmaceuticals
$100,449$48.29
Horizon Pharma USA, Inc.
$95,235$45.79
Zogenix
$78,507$37.74
Avion Pharmaceuticals
$76,104$36.59
DUSA Pharmaceuticals
$75,706$36.40
Wraser Pharmaceutical
$74,554$35.84
Santarus
$74,381$35.76
Aqua Pharmaceuticals
$73,824$35.49
Shionogi
$73,350$35.26
Pernix Therapeutics Holdings
$73,345$35.26
Ortho Dermatologics
$73,213$35.20
Arbor Pharmaceuticals
$73,142$35.16
Mission Pharmacal
$72,806$35.00
PruGen Pharmaceuticals
$72,717$34.96
Akrimax Pharmaceuticals
$72,422$34.82
Primus Pharmaceuticals
$72,356$34.79
Brad Pharm
$72,231$34.73
Topix Pharmaceuticals
$72,166$34.70
FarmVet
$72,079$34.65

Do you work at Quinnova Pharmaceuticals Including Sarms, Peptides and More?

Is Quinnova Pharmaceuticals Including Sarms, Peptides and More able to compete effectively with similar companies?

Quinnova Pharmaceuticals Including Sarms, Peptides and More jobs

Quinnova Pharmaceuticals Including Sarms, Peptides and More demographics vs competitors

Compare gender at Quinnova Pharmaceuticals Including Sarms, Peptides and More vs competitors

Job titleMaleFemale
Shionogi45%55%
Primus Pharmaceuticals46%54%
Zogenix51%49%
Horizon Pharma USA, Inc.55%45%
Arbor Pharmaceuticals55%45%
Quinnova Pharmaceuticals Including Sarms, Peptides and More--
Male
Female
100%
75%
50%
25%
0%

Quinnova Pharmaceuticals Including Sarms, Peptides and More

0%
25%
50%
75%
100%

Compare race at Quinnova Pharmaceuticals Including Sarms, Peptides and More vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
60%18%9%9%4%
6.9
65%10%16%5%4%
7.8
61%13%12%8%5%
9.0
61%14%14%8%4%
9.7
60%21%11%5%4%
6.6
60%12%20%5%2%
6.8

Quinnova Pharmaceuticals Including Sarms, Peptides and More and similar companies CEOs

CEOBio

An intuitive leader who engenders a deep level of trust and loyalty while providing a clear vision and business strategy, with a proven track record in the pharmaceutical, generic, biotechnology and consumer product industries. Recognized for entrepreneurial leadership approach to turnaround and rapid growth environments, leveraging strategic creativity, consumer and professional customer insight, merger and acquisition experience and operational expertise, all driving shareholder value. Open to contract C-level and Board of Director positions.

Stephen J. Farr
Zogenix

Stephen J. Farr, Ph.D. is one of our co-founders and has served as our President and as a member of our board of directors since August 2006. From 1995 to August 2006, Dr. Farr held positions of increasing responsibility within pharmaceutical sciences and research and development at Aradigm Corporation, and he served most recently as Senior Vice President and Chief Scientific Officer. In 2003, he played a key role in identifying and acquiring the DosePro technology and became technical director and executive sponsor for the development of sumatriptan DosePro at Aradigm Corporation. From 1986 to 1994, Dr. Farr was a tenured professor at the Welsh School of Pharmacy, Cardiff University, United Kingdom, concentrating in the areas of physical pharmacy and biopharmaceutics. He is a fellow of the American Association of Pharmaceutical Scientists and visiting Associate Professor in the Department of Pharmaceutics, School of Pharmacy, Virginia Commonwealth University. Dr. Farr is a registered pharmacist in the United Kingdom and obtained his Ph.D. degree in Pharmaceutics from the University of Wales.

Timothy P. Walbert
Horizon Pharma USA, Inc.

Neill “Gobie” Walsdorf
Mission Pharmacal

Nathan McCutcheon
Shionogi

Daniel Glassman
Brad Pharm

J.D. Weir is a Chief Executive Officer at PRIMUS PHARMACEUTICALS INC and is based in United States.

Quinnova Pharmaceuticals Including Sarms, Peptides and More competitors FAQs

Search for jobs